About this talk
Since its advent, there have been numerous conflicting reports about whether immunotherapy will be a “silver bullet” for different types of cancer, or if such expectations are based on hype or limited evidence. Many of the misconceptions about immunotherapy’s potential are due to our limited understanding of the immune system and how it serves to protect us from disease.
A pioneer in cancer care treatment, oncologist Lennie Sender has a deep understanding of both the possibilities and limitations of harnessing the immune system to treat different types of cancer. Check out Lennie’s 2017 TEDMED Talk for his straightforward report of the state of cancer immunotherapy options today and the promise they may hold for the future.
About Lennie Sender
See more
Leonard Sender is a leading oncologist and a pioneer in the treatment of cancer in adolescents and young adults (AYA). He is a professor at the University of California, Irvine School of Medicine and the Director of the AYA Cancer Program at CHOC Children’s Hospital. Lennie’s work focuses on the unique challenges faced by cancer patients between the ages of 15 and 39. This age group is often overlooked in research and treatment, but they have distinct needs. His program addresses these challenges, including how to preserve fertility, manage the long-term effects of treatment, and provide emotional support. As an innovative leader, Lennie conducts extensive research to improve the outcomes and quality of life for AYA patients. His work goes beyond the hospital; he is a founding member of SeventyK.org and a Chairman Emeritus of the Stupid Cancer organization, both of which are dedicated to raising awareness and providing support for young adults with cancer. His efforts have helped create a new field of medicine and have given a voice to a community that desperately needs it.
